Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.

Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH.

Alzheimers Dement (N Y). 2019 Apr 9;5:107-117. doi: 10.1016/j.trci.2019.02.001. eCollection 2019. Review.

2.

Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, Marder KS, Moy CS, Phelps CH, Scott PA, Seeley WW, Sieber BA, Silverberg NB, Sutherland ML, Taylor A, Torborg CL, Waddy SP, Gubitz AK, Holtzman DM.

Neurology. 2017 Dec 5;89(23):2381-2391. doi: 10.1212/WNL.0000000000004717. Epub 2017 Nov 8. Review.

3.

Translational Stroke Research: Vision and Opportunities.

Bosetti F, Koenig JI, Ayata C, Back SA, Becker K, Broderick JP, Carmichael ST, Cho S, Cipolla MJ, Corbett D, Corriveau RA, Cramer SC, Ferguson AR, Finklestein SP, Ford BD, Furie KL, Hemmen TM, Iadecola C, Jakeman LB, Janis S, Jauch EC, Johnston KC, Kochanek PM, Kohn H, Lo EH, Lyden PD, Mallard C, McCullough LD, McGavern LM, Meschia JF, Moy CS, Perez-Pinzon MA, Ramadan I, Savitz SI, Schwamm LH, Steinberg GK, Stenzel-Poore MP, Tymianski M, Warach S, Wechsler LR, Zhang JH, Koroshetz W.

Stroke. 2017 Sep;48(9):2632-2637. doi: 10.1161/STROKEAHA.117.017112. Epub 2017 Jul 27. Review. No abstract available.

4.

The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline.

Corriveau RA, Bosetti F, Emr M, Gladman JT, Koenig JI, Moy CS, Pahigiannis K, Waddy SP, Koroshetz W.

Cell Mol Neurobiol. 2016 Mar;36(2):281-8. doi: 10.1007/s10571-016-0334-7. Epub 2016 Apr 19. Review.

5.

Vascular contributions to cognitive impairment and dementia (VCID).

Murphy MP, Corriveau RA, Wilcock DM.

Biochim Biophys Acta. 2016 May;1862(5):857-9. doi: 10.1016/j.bbadis.2016.02.010. Epub 2016 Feb 26. No abstract available.

6.

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease.

Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC.

Alzheimers Dement. 2015 Jun;11(6):710-7. doi: 10.1016/j.jalz.2014.10.008. Epub 2014 Dec 12. Review.

7.

Recommendations of the Alzheimer's disease-related dementias conference.

Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, Sieber BA, Silverberg NB, Sutherland M, Torborg CL, Waddy SP, Zlokovic BV, Corriveau RA; ADRD 2013 Conference Organizing Committee.

Neurology. 2014 Aug 26;83(9):851-60. doi: 10.1212/WNL.0000000000000733. Epub 2014 Jul 30. Review.

8.

Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.

Wray S, Self M; NINDS Parkinson's Disease iPSC Consortium; NINDS Huntington's Disease iPSC Consortium; NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, Marti-Masso JF, Preza E, Barker S, Sutherland M, Corriveau RA, D'Andrea M, Schapira AH, Uitti RJ, Guttman M, Opala G, Jasinska-Myga B, Puschmann A, Nilsson C, Espay AJ, Slawek J, Gutmann L, Boeve BF, Boylan K, Stoessl AJ, Ross OA, Maragakis NJ, Van Gerpen J, Gerstenhaber M, Gwinn K, Dawson TM, Isacson O, Marder KS, Clark LN, Przedborski SE, Finkbeiner S, Rothstein JD, Wszolek ZK, Rossor MN, Hardy J.

PLoS One. 2012;7(8):e43099. doi: 10.1371/journal.pone.0043099. Epub 2012 Aug 27.

9.

CoAIMs: a cost-effective panel of ancestry informative markers for determining continental origins.

Londin ER, Keller MA, Maista C, Smith G, Mamounas LA, Zhang R, Madore SJ, Gwinn K, Corriveau RA.

PLoS One. 2010 Oct 15;5(10):e13443. doi: 10.1371/journal.pone.0013443.

10.

Use of calcium imaging for analysis of neuronal gap junction coupling.

Arumugam H, Denisova JV, Neve RL, Corriveau RA, Belousov AB.

Neurosci Lett. 2008 Nov 7;445(1):26-30. doi: 10.1016/j.neulet.2008.08.075. Epub 2008 Aug 31.

11.

Regulation of cholinergic phenotype in developing neurons.

Liu X, Popescu IR, Denisova JV, Neve RL, Corriveau RA, Belousov AB.

J Neurophysiol. 2008 May;99(5):2443-55. doi: 10.1152/jn.00762.2007. Epub 2008 Mar 5.

12.

Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.

Gwinn K, Corriveau RA, Mitsumoto H, Bednarz K, Brown RH Jr, Cudkowicz M, Gordon PH, Hardy J, Kasarskis EJ, Kaufmann P, Miller R, Sorenson E, Tandan R, Traynor BJ, Nash J, Sherman A, Mailman MD, Ostell J, Bruijn L, Cwik V, Rich SS, Singleton A, Refolo L, Andrews J, Zhang R, Conwit R, Keller MA; ALS Research Group.

PLoS One. 2007 Dec 5;2(12):e1254.

13.

Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery.

Keller MA, Gwinn K, Nash J, Horsford J, Zhang R, Rich SS, Corriveau RA.

Neuropsychiatr Dis Treat. 2007;3(5):613-8.

14.

Gap junctions are required for NMDA receptor dependent cell death in developing neurons.

de Rivero Vaccari JC, Corriveau RA, Belousov AB.

J Neurophysiol. 2007 Nov;98(5):2878-86. Epub 2007 Sep 12.

15.

NMDA receptors promote survival in somatosensory relay nuclei by inhibiting Bax-dependent developmental cell death.

de Rivero Vaccari JC, Casey GP, Aleem S, Park WM, Corriveau RA.

Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16971-6. Epub 2006 Oct 31.

16.

NMDA receptors regulate developmental gap junction uncoupling via CREB signaling.

Arumugam H, Liu X, Colombo PJ, Corriveau RA, Belousov AB.

Nat Neurosci. 2005 Dec;8(12):1720-6. Epub 2005 Nov 20.

PMID:
16299502
17.

NARG2 encodes a novel nuclear protein with (S/T)PXX motifs that is expressed during development.

Sugiura N, Dadashev V, Corriveau RA.

Eur J Biochem. 2004 Dec;271(23-24):4629-37.

18.

Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus.

Adams SM, de Rivero Vaccari JC, Corriveau RA.

J Neurosci. 2004 Oct 20;24(42):9441-50.

19.

An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development.

Sugiura N, Adams SM, Corriveau RA.

J Biol Chem. 2003 Oct 10;278(41):40113-20. Epub 2003 Jul 29.

20.

N-methyl-D-aspartate receptors regulate a group of transiently expressed genes in the developing brain.

Sugiura N, Patel RG, Corriveau RA.

J Biol Chem. 2001 Apr 27;276(17):14257-63. Epub 2001 Jan 31.

21.

Electrical activity and gene expression in the development of vertebrate neural circuits.

Corriveau RA.

J Neurobiol. 1999 Oct;41(1):148-57. Review.

PMID:
10504202
22.
23.
24.

Expression of the nicotinic receptor alpha 7 gene in tendon and periosteum during early development.

Romano SJ, Corriveau RA, Schwarz RI, Berg DK.

J Neurochem. 1997 Feb;68(2):640-8.

25.

Novel subpopulation of neuronal acetylcholine receptors among those binding alpha-bungarotoxin.

Pugh PC, Corriveau RA, Conroy WG, Berg DK.

Mol Pharmacol. 1995 Apr;47(4):717-25.

PMID:
7723732
26.

Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during development.

Corriveau RA, Romano SJ, Conroy WG, Oliva L, Berg DK.

J Neurosci. 1995 Feb;15(2):1372-83.

27.

Supplemental Content

Loading ...
Support Center